Effects of high-intensity interval training on cardiometabolic biomarkers in patients with prostate cancer undergoing active surveillance: a randomized controlled trial.
Dong-Woo KangCatherine J FieldDhruvesh PatelAdrian S FaireyNormand G BouléChristina M Dieli-ConwrightKerry S CourneyaPublished in: Prostate cancer and prostatic diseases (2024)
The ERASE Trial showed that a 12-week aerobic HIIT program improved several cardiometabolic biomarkers in patients with prostate cancer on AS that may contribute to cardiovascular health benefits and potentially influence signaling pathways in the progression of prostate cancer. Further research is needed to confirm the effects of exercise on cardiometabolic markers in men with prostate cancer on AS and determine if these effects are associated with improved long-term clinical outcomes.